{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T05:49:06Z","timestamp":1789624146011,"version":"build-2803163510"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T00:00:00Z","timestamp":1703030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T00:00:00Z","timestamp":1703030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s10585-023-10245-3","type":"journal-article","created":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T08:02:18Z","timestamp":1703059338000},"page":"55-68","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Computational markers for personalized prediction of outcomes in non-small cell lung cancer patients with brain metastases"],"prefix":"10.1007","volume":"41","author":[{"given":"S\u00e9bastien","family":"Benzekry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pirmin","family":"Schlicke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Mogenet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Greillier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Tomasini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u00e9onore","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,20]]},"reference":[{"key":"10245_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394\u2013424","journal-title":"CA Cancer J Clin"},{"key":"10245_CR2","unstructured":"Cancer of the Lung and Bronchus-Cancer Stat Facts. SEER."},{"key":"10245_CR3","first-page":"547","volume":"5","author":"C Chargari","year":"2013","unstructured":"Chargari C, Dhermain F (2013) M\u00e9tastases c\u00e9r\u00e9brales d\u2019un cancer bronchique non \u00e0 petites cellules\u202f: du traitement standardis\u00e9 au traitement personnalis\u00e9. Rev Mal Respir Actual 5:547\u2013556","journal-title":"Rev Mal Respir Actual"},{"key":"10245_CR4","first-page":"4655","volume":"32","author":"E Tabouret","year":"2012","unstructured":"Tabouret E et al (2012) Recent trends in epidemiology of brain metastases: an overview. Anticancer Res 32:4655\u20134662","journal-title":"Anticancer Res"},{"key":"10245_CR5","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/BF02782192","volume":"17","author":"W Hall","year":"2000","unstructured":"Hall W, Djalilian H, Nussbaum E, Cho K (2000) Long-term survival with metastatic cancer to the brain. Med Oncol 17:279\u2013286","journal-title":"Med Oncol"},{"key":"10245_CR6","first-page":"499","volume":"2","author":"J Gauger","year":"2007","unstructured":"Gauger J, Patz EF, Coleman RE, Herndon JE (2007) Clinical stage I non-small cell lung cancer including FDG-PET Imaging: sites and time to recurrence. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer 2:499\u2013505","journal-title":"J Thorac Oncol Off Publ Int Assoc Study Lung Cancer"},{"key":"10245_CR7","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/S0022-5223(94)70293-4","volume":"108","author":"T Yano","year":"1994","unstructured":"Yano T et al (1994) The first site of recurrence after complete resection in non-small-cell carcinoma of the lung. J Thorac Cardiovasc Surg 108:680\u2013683","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10245_CR8","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1016\/j.cllc.2017.05.017","volume":"19","author":"S Sadoyama","year":"2018","unstructured":"Sadoyama S et al (2018) Isolated brain metastases as the first relapse after the curative surgical resection in non\u2013small-cell lung cancer patients with an EGFR mutation. Clin Lung Cancer 19:e29\u2013e36","journal-title":"Clin Lung Cancer"},{"key":"10245_CR9","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1056\/NEJM198805193182004","volume":"318","author":"RA Figlin","year":"1988","unstructured":"Figlin RA, Piantadosi S, Feld R, The Lung Cancer Study Group (1988) Intracranial recurrence of carcinoma after complete surgical resection of stage I, II, and III non-small-cell lung cancer. N Engl J Med 318:1300\u20131305","journal-title":"N Engl J Med"},{"key":"10245_CR10","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/annonc\/mdw326","volume":"27","author":"S Novello","year":"2016","unstructured":"Novello S, Barlesi F, Califano R, Cufer T, Ekman S, Levra MG, Kerr K, Popat S, Reck M, Senan S, Simo GV (2016) Metastatic non-small-cell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 27:v1-27","journal-title":"Ann Oncol"},{"key":"10245_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","volume":"13","author":"S Hellman","year":"1995","unstructured":"Hellman S, Weichselbaum RR (1995) Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease. J Clin Oncol Off J Am Soc Clin Oncol 13:8\u201310","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10245_CR12","doi-asserted-by":"publisher","first-page":"e81","DOI":"10.3747\/co.26.4116","volume":"26","author":"SA Laurie","year":"2019","unstructured":"Laurie SA et al (2019) Canadian consensus: oligoprogressive, pseudoprogressive, and oligometastatic non-small-cell lung cancer. Curr Oncol Tor Ont 26:e81\u2013e93","journal-title":"Curr Oncol Tor Ont"},{"key":"10245_CR13","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.21037\/tlcr-20-459","volume":"9","author":"JJAO Schoenmaekers","year":"2020","unstructured":"Schoenmaekers JJAO, Paats MS, Dingemans A-MC, Hendriks LEL (2020) Central nervous system metastases and oligoprogression during treatment with tyrosine kinase inhibitors in oncogene-addicted non-small cell lung cancer: how to treat and when? Transl Lung Cancer Res 9:2599\u20132617","journal-title":"Transl Lung Cancer Res"},{"key":"10245_CR14","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1002\/cncr.10687","volume":"95","author":"GL Ceresoli","year":"2002","unstructured":"Ceresoli GL et al (2002) Brain metastases in locally advanced nonsmall cell lung carcinoma after multimodality treatment: Risk factors analysis. Cancer 95:605\u2013612","journal-title":"Cancer"},{"key":"10245_CR15","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1002\/1097-0142(19810715)48:2<384::AID-CNCR2820480227>3.0.CO;2-8","volume":"48","author":"S Zimm","year":"1981","unstructured":"Zimm S, Wampler GL, Stablein D, Hazra T, Young HF (1981) Intracerebral metastases in solid-tumor patients: natural history and results of treatment. Cancer 48:384\u2013394","journal-title":"Cancer"},{"key":"10245_CR16","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S1470-2045(14)70061-0","volume":"15","author":"M Yamamoto","year":"2014","unstructured":"Yamamoto M et al (2014) Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study. Lancet Oncol 15:387\u2013395","journal-title":"Lancet Oncol"},{"key":"10245_CR17","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1186\/s12885-017-3494-z","volume":"17","author":"JD Zindler","year":"2017","unstructured":"Zindler JD et al (2017) Whole brain radiotherapy versus stereotactic radiosurgery for 4\u201310 brain metastases: a phase III randomised multicentre trial. BMC Cancer 17:500","journal-title":"BMC Cancer"},{"key":"10245_CR18","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3171\/sup.2005.102.s_supplement.0075","volume":"102","author":"M Gerosa","year":"2005","unstructured":"Gerosa M, Nicolato A, Foroni R, Tomazzoli L, Bricolo A (2005) Analysis of long-term outcomes and prognostic factors in patients with non-small cell lung cancer brain metastases treated by gamma knife radiosurgery. J Neurosurg 102:75\u201380","journal-title":"J Neurosurg"},{"key":"10245_CR19","doi-asserted-by":"publisher","first-page":"e463","DOI":"10.1016\/j.ijrobp.2011.02.051","volume":"81","author":"M Motta","year":"2011","unstructured":"Motta M et al (2011) Gamma knife radiosurgery for treatment of cerebral metastases from non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 81:e463-468","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10245_CR20","first-page":"CD012086","volume":"8","author":"R Fuentes","year":"2018","unstructured":"Fuentes R et al (2018) Surgery versus stereotactic radiotherapy for people with single or solitary brain metastasis. Cochrane Database Syst Rev 8:CD012086","journal-title":"Cochrane Database Syst Rev"},{"key":"10245_CR21","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1056\/NEJM199908123410703","volume":"341","author":"A Aup\u00e9rin","year":"1999","unstructured":"Aup\u00e9rin A et al (1999) Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. N Engl J Med 341:476\u2013484","journal-title":"N Engl J Med"},{"key":"10245_CR22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3389\/fonc.2020.00011","volume":"10","author":"L Liu","year":"2020","unstructured":"Liu L et al (2020) The role of prophylactic cranial irradiation in patients with non-small cell lung cancer: an updated systematic review and meta-analysis. Front Oncol 10:11","journal-title":"Front Oncol"},{"key":"10245_CR23","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/S1470-2045(09)70263-3","volume":"10","author":"EL Chang","year":"2009","unstructured":"Chang EL et al (2009) Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 10:1037\u20131044","journal-title":"Lancet Oncol"},{"key":"10245_CR24","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1200\/JCO.2011.41.0639","volume":"31","author":"R Soffietti","year":"2013","unstructured":"Soffietti R et al (2013) A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results. J Clin Oncol Off J Am Soc Clin Oncol 31:65\u201372","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10245_CR25","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1158\/1078-0432.CCR-14-2082","volume":"21","author":"B Besse","year":"2015","unstructured":"Besse B et al (2015) Bevacizumab in patients with nonsquamous non-small cell lung cancer and asymptomatic, untreated brain metastases (BRAIN): a nonrandomized, phase II study. Clin Cancer Res Off J Am Assoc Cancer Res 21:1896\u20131903","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"10245_CR26","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1056\/NEJMoa1716948","volume":"378","author":"MA Socinski","year":"2018","unstructured":"Socinski MA et al (2018) Atezolizumab for first-line treatment of metastatic nonsquamous NSCLC. N Engl J Med 378:2288\u20132301","journal-title":"N Engl J Med"},{"key":"10245_CR27","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1056\/NEJMoa1606774","volume":"375","author":"M Reck","year":"2016","unstructured":"Reck M et al (2016) Pembrolizumab versus chemotherapy for PD-L1\u2013positive non\u2013small-cell lung cancer. N Engl J Med 375:1823\u20131833","journal-title":"N Engl J Med"},{"key":"10245_CR28","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1056\/NEJMoa1801005","volume":"378","author":"L Gandhi","year":"2018","unstructured":"Gandhi L et al (2018) Pembrolizumab plus chemotherapy in metastatic non\u2013small-cell lung cancer. N Engl J Med 378:2078\u20132092","journal-title":"N Engl J Med"},{"key":"10245_CR29","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1152\/physrev.00050.2017","volume":"99","author":"MD Sweeney","year":"2019","unstructured":"Sweeney MD, Zhao Z, Montagne A, Nelson AR, Zlokovic BV (2019) Blood-brain barrier: from physiology to disease and back. Physiol Rev 99:21\u201378","journal-title":"Physiol Rev"},{"key":"10245_CR30","doi-asserted-by":"publisher","first-page":"4265","DOI":"10.21873\/anticanres.13590","volume":"39","author":"D Cortinovis","year":"2019","unstructured":"Cortinovis D et al (2019) Italian cohort of the nivolumab EAP in squamous NSCLC: efficacy and safety in patients With CNS metastases. Anticancer Res 39:4265\u20134271","journal-title":"Anticancer Res"},{"key":"10245_CR31","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.lungcan.2016.05.031","volume":"98","author":"E Dudnik","year":"2016","unstructured":"Dudnik E et al (2016) Intracranial response to nivolumab in NSCLC patients with untreated or progressing CNS metastases. Lung Cancer Amst Neth 98:114\u2013117","journal-title":"Lung Cancer Amst Neth"},{"key":"10245_CR32","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/S1470-2045(16)30053-5","volume":"17","author":"SB Goldberg","year":"2016","unstructured":"Goldberg SB et al (2016) Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial. Lancet Oncol 17:976\u2013983","journal-title":"Lancet Oncol"},{"key":"10245_CR33","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.lungcan.2017.12.008","volume":"116","author":"C Gauvain","year":"2018","unstructured":"Gauvain C et al (2018) Intracerebral efficacy and tolerance of nivolumab in non\u2013small-cell lung cancer patients with brain metastases. Lung Cancer 116:62\u201366","journal-title":"Lung Cancer"},{"key":"10245_CR34","doi-asserted-by":"publisher","first-page":"9502","DOI":"10.1200\/JCO.2020.38.15_suppl.9502","volume":"38","author":"NB Leighl","year":"2020","unstructured":"Leighl NB et al (2020) CCTG BR.34: a randomized trial of durvalumab and tremelimumab +\/- platinum-based chemotherapy in patients with metastatic (Stage IV) squamous or nonsquamous non-small cell lung cancer (NSCLC). J Clin Oncol 38:9502\u20139502","journal-title":"J Clin Oncol"},{"key":"10245_CR35","doi-asserted-by":"publisher","first-page":"v606","DOI":"10.1093\/annonc\/mdz260.005","volume":"30","author":"SF Powell","year":"2019","unstructured":"Powell SF et al (2019) Pembrolizumab (pembro) plus platinum-based chemotherapy (chemo) in NSCLC with brain metastases: Pooled analysis of KEYNOTE-021, 189, and 407. Ann Oncol 30:v606\u2013v607","journal-title":"Ann Oncol"},{"key":"10245_CR36","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.tranon.2018.07.003","volume":"11","author":"X Wang","year":"2018","unstructured":"Wang X, Xu Y, Tang W, Liu L (2018) Efficacy and safety of radiotherapy plus EGFR-TKIs in NSCLC patients with brain metastases: a meta-analysis of published data. Transl Oncol 11:1119\u20131127","journal-title":"Transl Oncol"},{"key":"10245_CR37","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ejca.2018.01.067","volume":"93","author":"A Levy","year":"2018","unstructured":"Levy A et al (2018) Diversity of brain metastases screening and management in non-small cell lung cancer in Europe: results of the European Organisation for Research and Treatment of Cancer Lung Cancer Group survey. Eur J Cancer 93:37\u201346","journal-title":"Eur J Cancer"},{"key":"10245_CR38","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/S0360-3016(96)00619-0","volume":"37","author":"L Gaspar","year":"1997","unstructured":"Gaspar L et al (1997) Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials. Int J Radiat Oncol 37:745\u2013751","journal-title":"Int J Radiat Oncol"},{"key":"10245_CR39","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.ijrobp.2014.07.002","volume":"90","author":"PW Sperduto","year":"2014","unstructured":"Sperduto PW et al (2014) Secondary analysis of RTOG 9508, a phase 3 randomized trial of whole-brain radiation therapy versus WBRT plus stereotactic radiosurgery in patients with 1\u20133 brain metastases; poststratified by the graded prognostic assessment (GPA). Int J Radiat Oncol Biol Phys 90:526\u2013531","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10245_CR40","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1001\/jamaoncol.2016.3834","volume":"3","author":"PW Sperduto","year":"2017","unstructured":"Sperduto PW et al (2017) Estimating survival in patients with lung cancer and brain metastases: an update of the graded prognostic assessment for lung cancer using molecular markers (Lung-molGPA). JAMA Oncol 3:827\u2013831","journal-title":"JAMA Oncol"},{"key":"10245_CR41","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.lungcan.2004.01.025","volume":"45","author":"A Bajard","year":"2004","unstructured":"Bajard A et al (2004) Multivariate analysis of factors predictive of brain metastases in localised non-small cell lung carcinoma. Lung Cancer 45:317\u2013323","journal-title":"Lung Cancer"},{"key":"10245_CR42","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s11060-017-2574-x","volume":"135","author":"N Hayashi","year":"2017","unstructured":"Hayashi N et al (2017) Negative impact of leukoaraiosis on the incidence of brain metastases in patients with lung cancer. J Neurooncol 135:299\u2013306","journal-title":"J Neurooncol"},{"key":"10245_CR43","doi-asserted-by":"publisher","first-page":"535","DOI":"10.2307\/2529743","volume":"32","author":"LA Liotta","year":"1976","unstructured":"Liotta LA, Saidel GM, Kleinerman J (1976) Stochastic model of metastases formation. Biometrics 32:535\u2013550","journal-title":"Biometrics"},{"key":"10245_CR44","doi-asserted-by":"publisher","first-page":"6397","DOI":"10.1158\/0008-5472.CAN-14-0721","volume":"74","author":"N Hartung","year":"2014","unstructured":"Hartung N et al (2014) Mathematical modeling of tumor growth and metastatic spreading: validation in tumor-bearing mice. Cancer Res 74:6397\u20136407","journal-title":"Cancer Res"},{"key":"10245_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1004626","volume":"11","author":"E Baratchart","year":"2015","unstructured":"Baratchart E et al (2015) Computational modelling of metastasis development in renal cell carcinoma. PLoS Comput Biol 11:e1004626","journal-title":"PLoS Comput Biol"},{"key":"10245_CR46","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1158\/0008-5472.CAN-15-1389","volume":"76","author":"S Benzekry","year":"2016","unstructured":"Benzekry S et al (2016) Modeling spontaneous metastasis following surgery: an in vivo-in silico approach. Cancer Res 76:535\u2013547","journal-title":"Cancer Res"},{"key":"10245_CR47","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/bjc.1965.32","volume":"19","author":"AK Laird","year":"1965","unstructured":"Laird AK (1965) Dynamics of tumour growth: comparison of growth rates and extrapolation of growth curve to one cell. Br J Cancer 19:278\u2013291","journal-title":"Br J Cancer"},{"key":"10245_CR48","first-page":"7067","volume":"48","author":"L Norton","year":"1988","unstructured":"Norton L (1988) A Gompertzian model of human breast cancer growth. Cancer Res 48:7067\u20137071","journal-title":"Cancer Res"},{"key":"10245_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1003800","volume":"10","author":"S Benzekry","year":"2014","unstructured":"Benzekry S et al (2014) Classical mathematical models for description and prediction of experimental tumor growth. PLoS Comput Biol 10:e1003800","journal-title":"PLoS Comput Biol"},{"key":"10245_CR50","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1006\/jtbi.2000.1075","volume":"203","author":"K Iwata","year":"2000","unstructured":"Iwata K, Kawasaki K, Shigesada N (2000) A dynamical model for the growth and size distribution of multiple metastatic tumors. J Theor Biol 203:177\u2013186","journal-title":"J Theor Biol"},{"key":"10245_CR51","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12976-021-00142-1","volume":"18","author":"P Schlicke","year":"2021","unstructured":"Schlicke P, Kuttler C, Schumann C (2021) How mathematical modeling could contribute to the quantification of metastatic tumor burden under therapy: insights in immunotherapeutic treatment of non-small cell lung cancer. Theor Biol Med Model 18:11","journal-title":"Theor Biol Med Model"},{"key":"10245_CR52","doi-asserted-by":"publisher","DOI":"10.1200\/CCI.19.00133","author":"C Nicol\u00f2","year":"2020","unstructured":"Nicol\u00f2 C et al (2020) Machine learning and mechanistic modeling for prediction of metastatic relapse in early-stage breast cancer. JCO Clin Cancer Inform. https:\/\/doi.org\/10.1200\/CCI.19.00133","journal-title":"JCO Clin Cancer Inform"},{"key":"10245_CR53","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12943-021-01416-5","volume":"20","author":"LS Cooley","year":"2021","unstructured":"Cooley LS et al (2021) Experimental and computational modeling for signature and biomarker discovery of renal cell carcinoma progression. Mol Cancer 20:136","journal-title":"Mol Cancer"},{"key":"10245_CR54","doi-asserted-by":"publisher","DOI":"10.1200\/CCI.20.00092","author":"S Benzekry","year":"2021","unstructured":"Benzekry S, Sentis C, Coze C, Tessonnier L, Andr\u00e9 N (2021) Development and validation of a prediction model of overall survival in high-risk neuroblastoma using mechanistic modeling of metastasis. JCO Clin Cancer Inform. https:\/\/doi.org\/10.1200\/CCI.20.00092","journal-title":"JCO Clin Cancer Inform"},{"key":"10245_CR55","doi-asserted-by":"publisher","first-page":"13018","DOI":"10.1038\/s41598-019-49407-3","volume":"9","author":"M Bilous","year":"2019","unstructured":"Bilous M et al (2019) Quantitative mathematical modeling of clinical brain metastasis dynamics in non-small cell lung cancer. Sci Rep 9:13018","journal-title":"Sci Rep"},{"key":"10245_CR56","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/jso.2930600216","volume":"60","author":"JS Spratt","year":"1995","unstructured":"Spratt JS, Meyer JS, Spratt JA (1995) Rates of growth of human solid neoplasms: Part I. J Surg Oncol 60:137\u2013146","journal-title":"J Surg Oncol"},{"key":"10245_CR57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1007178","volume":"16","author":"C Vaghi","year":"2020","unstructured":"Vaghi C et al (2020) Population modeling of tumor growth curves and the reduced Gompertz model improve prediction of the age of experimental tumors. PLOS Comput Biol 16:e1007178","journal-title":"PLOS Comput Biol"},{"key":"10245_CR58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035689","volume":"7","author":"A Bethge","year":"2012","unstructured":"Bethge A, Schumacher U, Wree A, Wedemann G (2012) Are metastases from metastases clinical relevant? Computer modelling of cancer spread in a case of hepatocellular carcinoma. PLoS ONE 7:e35689","journal-title":"PLoS ONE"},{"key":"10245_CR59","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nrc2627","volume":"9","author":"CA Klein","year":"2009","unstructured":"Klein CA (2009) Parallel progression of primary tumours and metastases. Nat Rev Cancer 9:302\u2013312","journal-title":"Nat Rev Cancer"},{"key":"10245_CR60","unstructured":"MathWorks: MATLAB Documentary GlobalSearch."},{"key":"10245_CR61","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1287\/ijoc.1060.0175","volume":"19","author":"Z Ugray","year":"2007","unstructured":"Ugray Z et al (2007) Scatter search and local NLP solvers: a multistart framework for global optimization. Inf J Comput 19:328\u2013340","journal-title":"Inf J Comput"},{"key":"10245_CR62","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1136\/bmj.328.7447.1073","volume":"328","author":"JM Bland","year":"2004","unstructured":"Bland JM, Altman DG (2004) The logrank test. BMJ 328:1073","journal-title":"BMJ"},{"key":"10245_CR63","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.21105\/joss.01317","volume":"4","author":"C Davidson-Pilon","year":"2019","unstructured":"Davidson-Pilon C (2019) lifelines: survival analysis in Python. J Open Source Softw 4:1317","journal-title":"J Open Source Softw"},{"key":"10245_CR64","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","volume":"15","author":"FE Harrell","year":"1996","unstructured":"Harrell FE, Lee KL, Mark DB (1996) Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15:361\u2013387","journal-title":"Stat Med"},{"key":"10245_CR65","doi-asserted-by":"crossref","unstructured":"Pope WB (2018) Brain metastases: neuroimaging. In: Handbook of clinical neurology. Elsevier, vol 149, pp. 89\u2013112","DOI":"10.1016\/B978-0-12-811161-1.00007-4"},{"key":"10245_CR66","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1200\/JCO.2017.72.7636","volume":"35","author":"KM Brindle","year":"2017","unstructured":"Brindle KM, Izquierdo-Garc\u00eda JL, Lewis DY, Mair RJ, Wright AJ (2017) Brain tumor imaging. J Clin Oncol 35:2432\u20132438","journal-title":"J Clin Oncol"},{"key":"10245_CR67","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.jid.2021.10.003","volume":"142","author":"M Azin","year":"2022","unstructured":"Azin M, Demehri S (2022) STK11 loss: a novel mechanism for melanoma metastasis with therapeutic implications. J Invest Dermatol 142:1007\u20131009","journal-title":"J Invest Dermatol"},{"key":"10245_CR68","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s10555-017-9726-5","volume":"37","author":"D Huang","year":"2018","unstructured":"Huang D et al (2018) Mutations of key driver genes in colorectal cancer progression and metastasis. Cancer Metastasis Rev 37:173\u2013187","journal-title":"Cancer Metastasis Rev"},{"key":"10245_CR69","doi-asserted-by":"publisher","first-page":"R49","DOI":"10.1186\/bcr3150","volume":"14","author":"H Wikman","year":"2012","unstructured":"Wikman H et al (2012) Relevance of PTEN loss in brain metastasis formation in breast cancer patients. Breast Cancer Res 14:R49","journal-title":"Breast Cancer Res"},{"key":"10245_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fneur.2020.00001","volume":"11","author":"P Lohmann","year":"2020","unstructured":"Lohmann P et al (2020) PET\/MRI radiomics in patients with brain metastases. Front Neurol 11:1","journal-title":"Front Neurol"},{"key":"10245_CR71","doi-asserted-by":"publisher","first-page":"368","DOI":"10.21037\/tlcr-20-361","volume":"10","author":"S Zhao","year":"2021","unstructured":"Zhao S et al (2021) MRI radiomic signature predicts intracranial progression-free survival in patients with brain metastases of ALK-positive non-small cell lung cancer. Transl Lung Cancer Res 10:368\u2013380","journal-title":"Transl Lung Cancer Res"},{"key":"10245_CR72","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s11060-019-03343-4","volume":"146","author":"C-Y Huang","year":"2020","unstructured":"Huang C-Y et al (2020) Radiomics as prognostic factor in brain metastases treated with Gamma Knife radiosurgery. J Neurooncol 146:439\u2013449","journal-title":"J Neurooncol"},{"key":"10245_CR73","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.610691","volume":"10","author":"J Zhang","year":"2021","unstructured":"Zhang J et al (2021) Computer tomography radiomics-based nomogram in the survival prediction for brain metastases from non-small cell lung cancer underwent whole brain radiotherapy. Front Oncol 10:610691","journal-title":"Front Oncol"},{"key":"10245_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.critrevonc.2012.12.007","volume":"87","author":"F Perlikos","year":"2013","unstructured":"Perlikos F, Harrington KJ, Syrigos KN (2013) Key molecular mechanisms in lung cancer invasion and metastasis: a comprehensive review. Crit Rev Oncol Hematol 87:1\u201311","journal-title":"Crit Rev Oncol Hematol"},{"key":"10245_CR75","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1023\/A:1005849301420","volume":"45","author":"MW Retsky","year":"1997","unstructured":"Retsky MW et al (1997) Computer simulation of a breast cancer metastasis model. Breast Cancer Res Treat 45:193\u2013202","journal-title":"Breast Cancer Res Treat"},{"key":"10245_CR76","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1038\/s41567-020-0978-6","volume":"16","author":"VM P\u00e9rez-Garc\u00eda","year":"2020","unstructured":"P\u00e9rez-Garc\u00eda VM et al (2020) Universal scaling laws rule explosive growth in human cancers. Nat Phys 16:1232\u20131237","journal-title":"Nat Phys"},{"key":"10245_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41540-023-00298-1","volume":"9","author":"B Oca\u00f1a-Tienda","year":"2023","unstructured":"Oca\u00f1a-Tienda B et al (2023) Growth exponents reflect evolutionary processes and treatment response in brain metastases. Npj Syst Biol Appl 9:1\u201311","journal-title":"Npj Syst Biol Appl"},{"key":"10245_CR78","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1097\/JTO.0000000000000022","volume":"9","author":"R Nakamura","year":"2014","unstructured":"Nakamura R et al (2014) Epidermal growth factor receptor mutations: effect on volume doubling time of non\u2013small-cell lung cancer patients. J Thorac Oncol 9:1340\u20131344","journal-title":"J Thorac Oncol"},{"key":"10245_CR79","doi-asserted-by":"publisher","first-page":"4387","DOI":"10.21037\/jtd.2017.10.58","volume":"9","author":"R Zhang","year":"2017","unstructured":"Zhang R et al (2017) Volume doubling time of lung adenocarcinomas considering epidermal growth factor receptor mutation status of exon 19 and 21: three-dimensional volumetric evaluation. J Thorac Dis 9:4387\u20134397","journal-title":"J Thorac Dis"},{"key":"10245_CR80","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.jtho.2017.12.006","volume":"13","author":"TP Robin","year":"2018","unstructured":"Robin TP et al (2018) Excellent outcomes with radiosurgery for multiple brain metastases in ALK and EGFR driven non-small cell lung cancer. J Thorac Oncol 13:715\u2013720","journal-title":"J Thorac Oncol"},{"key":"10245_CR81","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1056\/NEJMoa2027071","volume":"383","author":"Y-L Wu","year":"2020","unstructured":"Wu Y-L et al (2020) Osimertinib in resected EGFR -mutated non\u2013small-cell lung cancer. N Engl J Med 383:1711\u20131723","journal-title":"N Engl J Med"},{"key":"10245_CR82","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2202170","author":"PM Forde","year":"2022","unstructured":"Forde PM et al (2022) Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMoa2202170","journal-title":"N Engl J Med"},{"key":"10245_CR83","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/S0140-6736(21)02098-5","volume":"398","author":"E Felip","year":"2021","unstructured":"Felip E et al (2021) Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB\u2013IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial. The Lancet 398:1344\u20131357","journal-title":"The Lancet"},{"key":"10245_CR84","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/cas.13917","volume":"110","author":"H Endo","year":"2019","unstructured":"Endo H, Inoue M (2019) Dormancy in cancer. Cancer Sci 110:474\u2013480","journal-title":"Cancer Sci"},{"key":"10245_CR85","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ccell.2017.02.009","volume":"31","author":"DF Quail","year":"2017","unstructured":"Quail DF, Joyce JA (2017) The microenvironmental landscape of brain tumors. Cancer Cell 31:326\u2013341","journal-title":"Cancer Cell"},{"key":"10245_CR86","first-page":"252","volume":"2","author":"B Gompertz","year":"1833","unstructured":"Gompertz B (1833) On the nature of the function expressive of the law of human mortality, and on a new mode of determining the value of life contingencies: In a letter to Francis Baily, Esq. FRS & c. Philos Trans R Soc Lond 2:252\u2013253","journal-title":"Philos Trans R Soc Lond"},{"key":"10245_CR87","first-page":"760","volume":"21","author":"AE Casey","year":"1934","unstructured":"Casey AE (1934) The experimental alteration of malignancy with an homologous mammalian tumor material. I: results with intratesticular inoculation. Am J Cancer 21:760","journal-title":"Am J Cancer"}],"container-title":["Clinical &amp; Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-023-10245-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10585-023-10245-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-023-10245-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T12:07:04Z","timestamp":1706702824000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10585-023-10245-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,20]]},"references-count":87,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["10245"],"URL":"https:\/\/doi.org\/10.1007\/s10585-023-10245-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3367167\/v1","asserted-by":"object"}]},"ISSN":["0262-0898","1573-7276"],"issn-type":[{"value":"0262-0898","type":"print"},{"value":"1573-7276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,20]]},"assertion":[{"value":"18 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Non-small cell lung cancer is difficult to manage when brain metastases are present. This study presents a mathematical model that can be calibrated on individual patients\u2019 data early in the treatment course to explain the growth dynamics of brain metastases and demonstrates that the mathematically derived parameters can serve as predictive tool in clinical routine care.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}